Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults: A Randomized Control Trial

NCT07369024 is registered in ClinicalTrials.gov with Mohsen Saidinejad as lead sponsor.

NCT NCT07369024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07369024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults: A Randomized Control Trial
Lead sponsor
Mohsen Saidinejad
Phase
Phase 2
Overall status
Recruiting
Start date
September 10, 2026
Completion date
April 30, 2028
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ketamine infusion, pain management, sickle cell disease, vaso-occlusive crises, vaso-occlusive pain episode in sickle cell disease